Novartis takes full control of Alcon
Novartis takes full control of Alcon, and CNBC's David Faber has the details of the deal.
Novartis said early Friday morning that it would cut 1,960 jobs in the United States within the next few months to deal with the impending loss of revenue from a key drug and the loss of potential revenue from a drug the company hoped would help its cause.